| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥460.6B | ¥479.5B | -4.0% |
| Operating Income | ¥12.1B | ¥21.9B | -44.7% |
| Ordinary Income | ¥11.7B | ¥29.6B | -60.4% |
| Net Income | ¥6.6B | ¥19.1B | -65.5% |
| ROE | 1.0% | 2.1% | - |
Piorlax Corporation's fiscal 2026 third quarter results show revenue of 460.6 billion yen (YoY -4.0%), operating income of 12.1 billion yen (YoY -44.7%), ordinary income of 11.7 billion yen (YoY -60.4%), and net income of 6.6 billion yen (YoY -65.5%). The company experienced declining revenue and sharply deteriorating profitability. Gross profit margin stood at 22.0%, but SG&A expenses of 89.4 billion yen compressed operating margin to 2.6%. Total assets decreased to 1,018.4 billion yen from 1,054.6 billion yen, while total equity fell significantly to 649.1 billion yen from 917.8 billion yen, primarily driven by substantial treasury stock purchases.
Revenue declined 4.0% YoY to 460.6 billion yen, primarily driven by weakness in the Automobile-Related segment. The Automobile-Related segment generated sales of 421.0 billion yen (down from 439.8 billion yen in the prior year period, representing a 4.3% decline), while the Medical Equipment segment recorded sales of 39.6 billion yen (down from 39.8 billion yen, a 0.5% decline). The revenue contraction reflects challenging market conditions in the core automotive business.
On the profit side, operating income fell 44.7% to 12.1 billion yen despite gross profit margin maintaining at 22.0%. This sharp decline stemmed from segment profit deterioration and elevated corporate expenses. Automobile-Related segment profit decreased to 18.1 billion yen from 27.0 billion yen (down 33.0%), while Medical Equipment segment profit fell to 2.6 billion yen from 3.3 billion yen (down 21.8%). Unallocated corporate expenses increased to 8.6 billion yen from 8.4 billion yen, further pressuring margins. SG&A expenses remained elevated at 89.4 billion yen, representing 19.4% of sales.
Ordinary income declined more steeply at 60.4% to 11.7 billion yen, reflecting increased financial costs. Interest expenses of 1.6 billion yen and foreign exchange losses of 1.4 billion yen weighed on non-operating results. The interest burden coefficient of 0.744 indicates that approximately 26% of operating profit was consumed by financing costs, an elevated level relative to operating performance.
Net income fell 65.5% to 6.6 billion yen, further compressed by income taxes. The gap between operating income (12.1 billion yen) and profit before tax (9.0 billion yen) of approximately 3.1 billion yen primarily reflects the net negative impact of non-operating items. This pattern represents a revenue down/profit down scenario with disproportionate margin compression at the bottom line.
The Automobile-Related segment comprises the core business, accounting for 91.4% of total sales and 87.6% of segment profit. This segment generated revenue of 421.0 billion yen with operating income of 18.1 billion yen, representing a segment margin of 4.3%. Performance deteriorated from the prior year when the segment recorded sales of 439.8 billion yen and operating income of 27.0 billion yen (margin of 6.1%), indicating a 1.8 percentage point margin contraction. This decline reflects pressure from market conditions and operational challenges in the automotive business.
The Medical Equipment segment contributed 39.6 billion yen in revenue with operating income of 2.6 billion yen, yielding a segment margin of 6.5%. While representing only 8.6% of total sales, this segment maintains a higher profitability margin than the Automobile-Related segment. However, segment profit declined from 3.3 billion yen in the prior year (margin of 8.2%), showing a 1.7 percentage point margin erosion.
After allocating corporate expenses of 8.6 billion yen (primarily general administrative expenses not attributable to specific segments), consolidated operating income totaled 12.1 billion yen. The concentration of revenue and profit in the Automobile-Related segment means that performance variability in automotive markets directly impacts overall results.
[Profitability] ROE of 1.0% represents significant deterioration from the prior year level, driven by collapsing net profit margins. Operating margin of 2.6% compares unfavorably to typical manufacturing sector levels, reflecting both revenue pressure and cost structure challenges. Net profit margin of 1.4% indicates minimal bottom-line conversion efficiency. [Cash Quality] Cash and deposits of 263.3 billion yen provide coverage of 1.01 times against short-term borrowings of 260.0 billion yen, indicating adequate near-term liquidity on the surface. However, working capital efficiency has deteriorated with receivables turnover at 101 days, inventory turnover at 115 days, and cash conversion cycle extended to 183 days, all exceeding typical healthy thresholds. [Investment Efficiency] Total asset turnover of 0.452 reflects moderate asset utilization efficiency. The financial leverage ratio of 1.57 times indicates reasonable use of debt relative to equity. [Financial Health] Equity ratio of 63.7% remains in a healthy range, providing financial stability. Current ratio of 160.0% indicates satisfactory short-term debt coverage capacity. The concentration of all interest-bearing debt in short-term borrowings (260.0 billion yen, representing 100% of interest-bearing debt) presents refinancing risk considerations.
Cash and deposits increased to 263.3 billion yen, while the balance sheet shows significant changes in equity structure. Treasury stock expanded substantially from 54.0 billion yen in the prior year to 291.0 billion yen, indicating large-scale share repurchases totaling approximately 237 billion yen during the period. This capital allocation decision represents a major use of cash resources for shareholder returns. Working capital efficiency deteriorated with accounts receivable at 127.8 billion yen and inventories at 57.4 billion yen remaining elevated relative to sales levels. The extended receivables collection period of 101 days and inventory holding period of 115 days suggest cash tied up in operations. Current liabilities totaled 353.6 billion yen, with short-term borrowings of 260.0 billion yen representing the dominant component. The cash coverage ratio of 1.01 times short-term debt indicates basic liquidity adequacy, though the concentration of debt in short-term instruments creates rollover requirements. Construction in progress increased to 72.3 billion yen, indicating ongoing capital investment projects that will require future cash outflows upon completion.
Ordinary income of 11.7 billion yen compared to operating income of 12.1 billion yen indicates a net negative contribution of 0.4 billion yen from non-operating items. The primary components include interest expenses of 1.6 billion yen and foreign exchange losses of 1.4 billion yen, partially offset by equity method investment gains and other financial income. Non-operating expenses represent approximately 3.5% of revenue, with interest costs comprising 0.35% of sales. The interest burden coefficient of 0.744 (profit before tax divided by operating income) quantifies the impact of financing costs on profitability. This elevated financial cost burden relative to operating profit raises concerns about capital structure efficiency. Operating income represents core business performance of 2.6% margin, while non-operating factors further compress profitability to ordinary income margin of 2.5%. Without operating cash flow data for the quarterly period, direct assessment of earnings quality through cash conversion metrics is limited. However, the deterioration in working capital metrics (extended DSO and DIO) suggests potential constraints on cash generation relative to reported earnings.
Full-year guidance projects revenue of 612.0 billion yen (YoY -3.4%), operating income of 16.0 billion yen (YoY -32.8%), and ordinary income of 15.0 billion yen (YoY -55.9%). Against these targets, third quarter cumulative progress rates are: revenue 75.3%, operating income 75.8%, and ordinary income 78.0%. These progress rates slightly exceed the standard 75% benchmark for third quarter, indicating performance is tracking reasonably in line with full-year expectations. However, achieving the full-year operating income target of 16.0 billion yen requires fourth quarter operating income of approximately 3.9 billion yen, which would represent sequential improvement from the weak third quarter run rate. The company forecasts full-year EPS of 27.44 yen and annual dividend of 53.00 yen. Net income guidance of 7.0 billion yen implies a fourth quarter contribution of approximately 0.4 billion yen, indicating minimal profit contribution expected in the final quarter. No revisions to guidance were announced with these quarterly results, suggesting management maintains confidence in achieving year-end targets despite the challenging performance trajectory through the first nine months.
The company announced a second quarter dividend of 39.00 yen per share and forecasts a year-end dividend of 53.00 yen per share. Based on the disclosed dividend payments against net income of 6.6 billion yen for the nine-month period and average outstanding shares of 258.4 million, the calculated dividend payout ratio reaches 526.1%, substantially exceeding net income. This exceptionally high payout ratio indicates dividends are being paid from sources beyond current period earnings, likely drawing on retained earnings or cash reserves. The sustainability of this dividend policy warrants scrutiny given the sharp decline in profitability. Share repurchases were substantial during the period, with treasury stock increasing from 54.0 billion yen to 291.0 billion yen, representing approximately 237 billion yen in buybacks. This aggressive capital return through both dividends and repurchases results in a total shareholder return significantly exceeding current earnings generation capacity. The combination of high dividends and large-scale buybacks while operating income and net income declined sharply raises questions about capital allocation priorities and the sustainability of shareholder returns at current levels.
Automotive market exposure represents the primary business risk, with the Automobile-Related segment comprising over 91% of revenue. Segment profit in this core business declined 33.0% YoY to 18.1 billion yen, demonstrating vulnerability to industry conditions. Any further deterioration in automotive demand, particularly in key markets, would directly impact consolidated performance. Customer concentration within the automotive sector amplifies this exposure.
Refinancing risk stems from the debt structure, with 100% of interest-bearing debt (260.0 billion yen) concentrated in short-term borrowings. This configuration requires continuous rollover of substantial borrowings, exposing the company to refinancing availability and interest rate changes. The interest burden coefficient of 0.744 indicates that financing costs already consume approximately 26% of operating profit, and any increase in borrowing costs would further pressure profitability.
Working capital efficiency deterioration poses operational risk, with receivables turnover extended to 101 days, inventory turnover at 115 days, and cash conversion cycle reaching 183 days. These metrics exceed healthy thresholds and indicate cash tied up in operations. Extended collection periods raise credit risk from customers, while elevated inventory levels present obsolescence risk and working capital strain. The combination constrains cash generation capacity needed to support operations and shareholder returns.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of 1.0% falls significantly below the manufacturing industry median of 5.8%, placing the company in the lower quartile of sector peers. Operating margin of 2.6% compares unfavorably to industry median of 8.9%, indicating substantial profitability challenges relative to sector norms. Net profit margin of 1.4% trails the industry median of 6.5% by 5.1 percentage points, reflecting compressed bottom-line conversion efficiency.
Financial Health: Equity ratio of 63.7% aligns closely with industry median of 63.8%, indicating comparable financial stability to sector peers. Current ratio of 160.0% falls below the industry median of 287%, suggesting relatively lower short-term liquidity cushion compared to manufacturing sector standards, though still within acceptable ranges.
Efficiency: Asset turnover of 0.452 falls below the industry median of 0.56, indicating lower asset utilization efficiency. Receivables turnover of 101 days exceeds the industry median of 85 days by 16 days, while inventory turnover of 115 days slightly exceeds the industry median of 112 days, suggesting working capital efficiency challenges. Operating working capital turnover of 183 days significantly exceeds the industry median of 112 days, highlighting substantial room for improvement in cash conversion cycle management.
Growth: Revenue decline of 4.0% compares unfavorably to industry median growth of 2.8%, positioning the company in negative growth while the sector shows modest expansion. This underperformance in top-line trends contributes to the profitability gap versus peers.
※ Industry: Manufacturing (105 companies), Comparison: FY2025-Q3, Source: Proprietary analysis
The sharp profitability deterioration with operating margin compressed to 2.6% and ROE falling to 1.0% represents the most significant characteristic observed from the earnings data. Operating income declined 44.7% while revenue declined only 4.0%, indicating substantial operating leverage on the downside and potential structural cost challenges. The company's profitability metrics now substantially trail manufacturing industry medians, with ROE 4.8 percentage points below sector median and operating margin 6.3 percentage points below peers. Recovery in profitability requires both revenue stabilization in the core Automobile-Related segment and meaningful cost structure improvements, particularly in SG&A expense management.
Aggressive capital returns totaling approximately 237 billion yen in share repurchases combined with high dividend payments (payout ratio exceeding 500%) occurred during a period of sharp earnings decline. This capital allocation pattern raised treasury stock from 54.0 billion yen to 291.0 billion yen while equity fell from 917.8 billion yen to 649.1 billion yen. The sustainability of current shareholder return levels appears questionable given the mismatch with earnings generation capacity, warranting close monitoring of management's capital allocation rationale and future dividend policy.
Working capital efficiency deterioration with cash conversion cycle extended to 183 days (vs. industry median of 112 days) and elevated DSO of 101 days suggests operational execution challenges beyond top-line weakness. The combination of receivables collection delays, elevated inventory levels, and tight cash coverage of short-term debt (1.01 times) creates potential liquidity constraints if operating performance does not improve. Focus on working capital management, particularly receivables collection and inventory optimization, represents a necessary operational priority.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.